Skip to content

Simeprevir cures almost 80% of first-time co-infected hepatitis C patients

Prof. Douglas Dieterich of Mount Sinai School of Medicine discusses recent advances in treatment of hepatitis C and HIV co-infection at CROI 2014. Photo by Liz Highleyman / hivandhepatitis.com

Faldaprevir plus interferon and ribavirin cures hepatitis C in most people with HIV/HCV co-infection

Douglas Dieterich, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Six-week oral treatment can cure hard-to-treat hepatitis C patients

Anita Kohli, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in first two years of PARTNER study

Press conference at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

A cure may need multiple components, workshop delegates hear

A cure may need multiple components, workshop delegates hear

TB-HIV news from the 44th Union World Conference on Lung Health.

Older age associated with bigger increases in viral load and falls in CD4 count in patients not taking HIV treatment

Reconnecting patients lost to follow-up with care can prevent new HIV transmissions

Big gaps in engagement with HIV care and virological suppression between US states